Also Known As
[Often referred to by brand name. See MedlinePlus Medical Drug Information]
Formal Name
Phenytoin, total and free
This article was last reviewed on
This article waslast modified on
May 28, 2018.
At a Glance
Why Get Tested?

To determine the level of the drug phenytoin in your blood in order to maintain a therapeutic level and to detect potential for toxicity

When To Get Tested?

At regular intervals to monitor; as needed to detect low or toxic concentrations

Sample Required?

A blood sample drawn from a vein in your arm

Test Preparation Needed?

None

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Phenytoin is a drug that is used to treat some seizure disorders (see Epilepsy), including complex partial seizures (psychomotor seizures) and seizures that occurr during or after neurosurgery. Phenytoin may be used alone or with phenobarbital or other anticonvulsants. This test measures the amount of phenytoin in the blood.

Seizure disorders affect the brain's ability to transmit electrical impulses and to regulate nerve activity. During a seizure, someone may experience changes in consciousness, alterations in sight, smell, and taste, and may experience uncontrolled muscular convulsions in one or more parts of the body. Phenytoin works by reducing the electrical conductance among brain cells, blocking excessive electrochemical activity occurring in the brain during a seizure.

Anyone can experience a seizure at any age. In many cases, the cause of seizures is not known. The frequency and severity varies from person to person and may change over time. People may experience a single seizure and never have another, may have occasional seizures, or may have recurrent seizures. In rare cases, a person may have a seizure that starts and does not stop without prompt medical intervention.

Phenytoin is prescribed to help prevent the recurrence of certain types of seizures. It has been widely used in the United States since its development in 1938. It is still being prescribed but is beginning to be replaced by newer drugs.

The level of phenytoin in the blood must be maintained within a narrow therapeutic range. If levels are too low, the affected person may experience seizures; if they are too high, the person may experience symptoms associated with phenytoin toxicity. These may include loss of balance and falling, involuntary eye movement from side to side (nystagmus), confusion, slurred speech, tremors, and low blood pressure.

Maintaining a therapeutic level of phenytoin in the blood can be a challenge. Enzymes in the liver process phenytoin at rates that differ from person to person and are affected by age (children metabolize it more quickly while the elderly metabolize it more slowly) and by the health of the liver. When the body has reached its capacity to process phenytoin, small increases in the dose can cause large increases in blood concentration, increasing the severity of side effects and causing phenytoin toxicity.

Phenytoin's total effect can be unpredictable. Dosages must be adjusted slowly until a steady concentration in the blood is reached. The actual amount of drug that it takes to reach this steady state will vary from person to person and may change over time. Health practitioners must also watch for side effects and adverse reactions during initial dosage adjustment and over time. In some cases, the severity of side effects may make it necessary to consider another anti-seizure medication.

Most phenytoin is bound to protein in the bloodstream; it is the unbound "free" portion that is active. If a person has a lower than normal amount of protein in their blood, such as low albumin in liver failure, then the person may have an excess of active phenytoin. Phenytoin can also interact with other drugs and increase or decrease the other medications' effectiveness. it is important to always discuss with a health practitioner all medications being taken to determine if drug interactions are a possibility.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

No test preparation is needed.

Accordion Title
Common Questions
  • How is it used?

    The phenytoin test is used to measure and monitor the amount of phenytoin in the blood and to determine whether drug concentrations are in the therapeutic range. It may be ordered every few days when a person first begins taking phenytoin to help adjust the dose to the desired blood level. The test is then ordered at regular intervals and as needed to monitor blood concentrations. One or more phenytoin tests may be ordered if a person starts or stops taking additional medications (to judge their effect, if any, on phenytoin levels) and may be ordered if the person has a seizure or if a health practitioner suspects toxicity.

    Usually, a total phenytoin test is used to monitor levels. In the blood, phenytoin is highly bound to serum proteins. Only the portion of phenytoin that is unbound or "free" is pharmacologically active. Under normal conditions, the balance between bound and unbound phenytoin in the blood is relatively stable, so measuring the total phenytoin (bound plus unbound) is appropriate for monitoring therapeutic levels. However, in certain conditions and disease states, that balance can be upset, the percentage of free or active phenytoin can increase, and the person may experience symptoms of toxicity even though their total phenytoin result falls within therapeutic range. In such cases, health practitioners may order a free phenytoin test to monitor the person's levels.

  • When is it ordered?

    Phenytoin is ordered frequently when a person begins phenytoin treatment and when/if a person's medications change (other drugs are started, stopped, or changed) or if there is a change in the status of their health. Once stable blood concentrations in the therapeutic range have been achieved, phenytoin is monitored at regular intervals to ensure that it remains in this range.

    The test may be ordered when a person's condition does not appear to be responding to phenytoin (e.g, he or she continues to have seizures) to determine whether the concentration is too low, the medication is ineffective, and/or to determine if the person is complying with therapy (taking the phenytoin regularly). The test may also be ordered when a person experiences side effects and/or exhibits symptoms that the health practitioner suspects may be due to toxicity. Toxic symptoms can affect the mouth, cardiovascular and nervous systems, and the eyes and include:

    • Swelling of the gums and/or lymph nodes
    • Hirsutism
    • Insomnia
    • Nausea
    • Confusion and irritability
    • Difficulty swallowing
    • Fatigue
    • Fever
    • Rashes
    • Involuntary eye movement
    • Abnormal heartbeat
    • Low blood pressure

    A free phenytoin level may be ordered when a person has a condition in which the percentage of free or active phenytoin may be increased. Some examples of these conditions include:

  • What does the test result mean?

    The therapeutic ranges for adults taking phenytoin have been established at 10.0-20.0 mcg/mL for total phenytoin (bound plus unbound) and 1.0-2.0 mcg/mL for free phenytoin (unbound only). The range for percent free phenytoin is 8-14%.

    Within these ranges, most people will respond to the drug without symptoms of toxicity. Response and side effects will be individual, however. Some people will experience seizures at the low end of the therapeutic range and some people will experience excessive side effects at the upper end. People should work closely with their health practitioner to find the dosage and concentration that works the best for them.

    In general, when phenytoin results are in the therapeutic range, the person is not having recurrent seizures and is not experiencing significant side effects, then the dosage of phenytoin is adequate. People should not increase, decrease, or stop taking their medication without consulting with their health care provider as it can increase their risk of having a seizure and may affect other medications that they are taking. Dosage determinations and adjustments must be evaluated on a case-by-case basis.

  • Is there anything else I should know?

    People who take phenytoin long-term may develop vitamin D deficiency, numbness in their extremities due to nerve damage (peripheral neuropathy), acne, excessive hair on their face or body, a thickening of facial features, or weakness of their bones. Rarely, a person may develop a severe rash and skin condition that requires hospitalization.

    Women who use phenytoin during pregnancy are at an increased risk of having babies born with several types of birth defects. Women who want to become pregnant should talk to their health practitioner.

    Phenytoin is sometimes prescribed for other conditions such as trigeminal neuralgia, which causes episodes of sharp pain along the jaw, and other causes of nerve pain. This use must also be monitored.

    Phenytoin is not effective for every kind of seizure and will not work for every person.

    A large variety of prescribed drugs, over-the-counter medications, and supplements can increase, decrease, or interfere with the concentration of phenytoin in the blood and its effects. Drugs whose effects are reduced by phenytoin include corticosteroids such as prednisone, estrogens, warfarin, and some antidepressants. Phenytoin also can reduce the effectiveness of oral contraceptives and other forms of birth control such as Depo-Provera or implants. Drugs that may increase phenytoin blood levels and toxicity include alcohol, diazepam, certain antidepressants, and omeprazole. The oral absorption of phenytoin can be reduced by antacids containing magnesium, calcium carbonate, calcium salts, or enteral feeding products. Many more drugs interact with phenytoin, so tell your health practitioner about any prescription or over-the-counter drugs, supplements, or herbal products you take.

  • How long will I need to be on phenytoin?
    Phenytoin or another anti-seizure medication is usually taken every day (sometimes several times a day) for a person's lifetime. An exception to this may be people whose seizures are caused by a temporary condition; they may only need the medication for a short period of time.
  • How is phenytoin taken?
    It may be taken as a pill or a liquid. When a person has status epilepticus (an acute, continuing seizure), then phenytoin is given intravenously for rapid action.
  • Can I test my phenytoin level at home?
    No, it requires specialized equipment. Blood samples are collected from a vein in the arm and tested in the laboratory.
View Sources

Sources Used in Current Review

Phenytoin. Medline Plus. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682022.html. Last Revised 05/01/2009. Accessed February 13, 2014.

Dilantin. RxList.com. Available online at http://www.rxlist.com/dilantin-drug.htm through http://www.rxlist.com. Last updated February 7, 2014. Accessed February 13, 2014.

Charlene Miller et al. Phenytoin Toxicity Clinical Presentation. Medscape. Available online at http://emedicine.medscape.com/article/816447-clinical#a0217through http://emedicine.medscape.com. Last updated November 9, 2012. Accessed February 13, 2014.

Phenytoin (Phenytek, Dilantin). NYU Langone Medical Center. Available online at http://epilepsy.med.nyu.edu/treatment/medications/phenytoin#sthash.5jYjrrwC.dpbs through http://epilepsy.med.nyu.edu. Accessed February 13, 2014.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

(2003 April 1, Revised). Phenytoin Oral. MedlinePlus Drug Information [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682022.html.

Whetstone, W. (2005 May 10, Revised). Phenytoin Overdose. MedlinePlus Drug Information [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682022.html.

Wilner, A. (2004 October 11). The Epilepsy Continuum: From Age to Age. Medscape [On-line CME]. Available online at http://www.medscape.com/viewarticle/489615 through http://www.medscape.com.

Pack, A. (2006 April 28). Therapy Insight: Clinical Management of Pregnant Women With Epilepsy. Medscape from Nat Clin Pract Neurol. 2006;2(4):190-200 [On-line information]. Available online at http://www.medscape.com/viewarticle/530483 through http://www.medscape.com.

Holloway, R. and Jozefowicz, R. (2006 March). Update in Neurology. Ann Intern Med 2006:144:421-426 [On-line journal]. PDF available for download at http://www.annals.org/cgi/reprint/144/6/421.pdf through http://www.annals.org.

(© 2006). Phenytoin, Free & Total. ARUP's Laboratory Test Directory [On-line information]. Available online at http://www.aruplab.com/guides/ug/tests/0090141.jsp through http://www.aruplab.com/.

Morantz, C. and Torrey, B. (2005 January 15). Guidelines for Prescribing Antiepileptic Drugs. American Family Physician: v71(2) [On-line information]. Available online at http://www.aafp.org/afp/20050115/practice.html through http://www.aafp.org.

(© 2006). Phenytoin. Epilepsy.com [On-line information]. Available online at http://www.epilepsy.com/medications/a_phenytoin_intro.html through http://www.epilepsy.com.

(2003 February 1, revised). Seizure Disorders. Merck Manual Home Edition [On-line information]. Available online at http://www.merck.com/mmhe/print/sec06/ch085/ch085a.html through http://www.merck.com.

McMillin GA; Juenke J; Dasgupta A ( Oct. 2005). Effect of ultrafiltrate volume on determination of free phenytoin concentration. Medscape from Ther Drug Monit. 2005; 27(5):630-3 (ISSN: 0163-4356). Available online at http://www.medscape.com/medline/abstract/16175137 through http://www.medscape.com.

Dasgupta A (Oct. 2002). Clinical utility of free drug monitoring. Medscape from Clin Chem Lab Med. 2002; 40(10):986-93 (ISSN: 1434-6621). Available online at http://www.medscape.com/medline/abstract/12476936 through http://www.medscape.com.

(Dec 30, 2008). von Winckelmann S, Spriet I, Willems L. Therapeutic Drug Monitoring of Phenytoin in Critically Ill Patients. MedScape. Available online at http://www.medscape.com/viewarticle/583862 through http://www.medscape.com. Accessed Sept 2010.

(Updated July 15, 2009). Miller C. Toxicity, Phenytoin. Medscape eMedicine. Available online at http://emedicine.medscape.com/article/816447-overview through http://emedicine.medscape.com. Accessed September 2010.

(Updated May 1, 2009). Phenytoin. MedlinePlus Drug Information [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682022.html. Accessed September 2010.

(Updated February 3, 2009). Duldner J, Phenytoin Overdose. Medline Plus Drug Information. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/002533.htm. Accessed September 2010.

Malaty W, Stiglemen S. Antiepileptic Drug Monitoring. Am Fam Physician. 2008 Aug 1;78(3):385-386. Available online at http://www.aafp.org/afp/2008/0801/p385.html through http://www.aafp.org. Accessed September 2010.

Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. St. Louis: Elsevier Saunders; 2006 Pp 1252, 2313.

Carl GF, Smith ML. Phenytoin-folate interactions: differing effects of the sodium salt and the free acid of phenytoin. Epilepsia 1992; 33(2):372-5. Available online at http://www.medscape.com.

Beckmann, Charles R, et al. Obstetrics and Gynecology. 4th Ed. Baltimore: Lippincott Williams & Wilkins, 2002.

Ask a Laboratory Scientist

 

Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, the American Society for Clinical Laboratory Science (ASCLS). Click on the Contact a Scientist button below to be re-directed to the ASCLS site to complete a request form. If your question relates to this web site and not to a specific lab test, please submit it via our Contact Us page instead. Thank you.

Contact a Scientist